 SAN DIEGO, Oct. 26, 2021 GLOBE NEWSWIRE -- eFFECTOR Therapeutics NASDAQ: EFTR, a leader in the development of selective translation regulator inhibitors STRIs for the treatment of cancer, today announced that management will participate in and host 1x1 meetings at the following upcoming investor conferences: 